Endoscopic and pathological aspects of colitis-associated dysplasia (Q37601306)

21 August 2017

1 reference

title

Endoscopic and pathological aspects of colitis-associated dysplasia (English)

1 reference

21 August 2017

4

Peter D Siersema

1 reference

21 August 2017

Fiona D M van Schaik

1

1 reference

21 August 2017

G Johan A Offerhaus

2

1 reference

21 August 2017

Marguerite E I Schipper

3

1 reference

21 August 2017

Frank P Vleggaar

5

1 reference

21 August 2017

Bas Oldenburg

6

1 reference

21 August 2017

language of work or name

English

0 references

publication date

22 September 2009

1 reference

Nature Reviews Gastroenterology & Hepatology

21 August 2017

published in

1 reference

21 August 2017

volume

6

1 reference

21 August 2017

issue

11

1 reference

21 August 2017

page(s)

671-678

1 reference

Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

The risk of colorectal cancer in ulcerative colitis: a meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

Cancer risk in patients with inflammatory bowel disease: a population-based study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

Polypoid dysplasia and adenomas in inflammatory bowel disease: a clinical, pathologic, and follow-up study of 89 polyps from 59 patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

Inter-observer variation between general and specialist gastrointestinal pathologists when grading dysplasia in ulcerative colitis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

Observer study of the grading of dysplasia in ulcerative colitis: comparison with clinical outcome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

Screening and Surveillance Colonoscopy in Chronic Crohn's Colitis: Results of a Surveillance Program Spanning 25 Years

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

High lifetime risk of cancer in primary sclerosing cholangitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

High frequency of early colorectal cancer in inflammatory bowel disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

Most dysplasia in ulcerative colitis is visible at colonoscopy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

Long-term follow-up after polypectomy treatment for adenoma-like dysplastic lesions in ulcerative colitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

Genetic alterations in chronic ulcerative colitis-associated adenoma-like DALMs are similar to non-colitic sporadic adenomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

Distinction between dysplasia-associated lesion or mass (DALM) and adenoma in patients with ulcerative colitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

Endoscopic and chromoendoscopic atlas featuring dysplastic lesions in surveillance colonoscopy for patients with long-standing ulcerative colitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

Is dysplasia visible during surveillance colonoscopy in patients with ulcerative colitis?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

Low-grade dysplasia in extensive, long-standing inflammatory bowel disease: a follow-up study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

Incidence and prognosis of colorectal dysplasia in inflammatory bowel disease: a population-based study from Olmsted County, Minnesota

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

Observer variation in the assessment of dysplasia in ulcerative colitis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

Interobserver variability in the diagnosis of ulcerative colitis-associated dysplasia by telepathology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

The p53 family and programmed cell death

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

Mutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

p53 protein expression in ulcerative colitis-associated colorectal dysplasia and carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

p53 immunohistochemistry of ulcerative colitis-associated with dysplasia and carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

Ki-67: a useful marker for the evaluation of dysplasia in ulcerative colitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

Immunohistochemical assessment of Ki67 and p53 expression assists the diagnosis and grading of ulcerative colitis-related dysplasia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

High proliferative activity is associated with dysplasia in ulcerative colitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

Increased expression of proliferative Ki-67 nuclear antigen is correlated with dysplastic colorectal epithelium in ulcerative colitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

Altered distribution of beta-catenin, and its binding proteins E-cadherin and APC, in ulcerative colitis-related colorectal cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

AMACR immunostaining is useful in detecting dysplastic epithelium in Barrett's esophagus, ulcerative colitis, and Crohn's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

Combined alpha-methylacyl coenzyme A racemase/p53 analysis to identify dysplasia in inflammatory bowel disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

Alpha-methylacyl-CoA racemase (AMACR) immunohistochemistry in Barrett's and colorectal mucosa: only significant overexpression favours a diagnosis of intraepithelial neoplasia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

Histologic and colonoscopic assessment of disease extension in ulcerative colitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

Gross versus microscopic pancolitis and the occurrence of neoplasia in ulcerative colitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

Risks and clinical features of colorectal cancer complicating Crohn's disease in Japanese patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

Ulcerative colitis and colorectal cancer. A population-based study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

Family history as a risk factor for colorectal cancer in inflammatory bowel disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

Familial predisposition for colorectal cancer in chronic ulcerative colitis: a case-control study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

Is there an excess risk for colorectal cancer in patients with ulcerative colitis and concomitant primary sclerosing cholangitis? A population based study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

Management of low and high-grade dysplasia in inflammatory bowel disease: the gastroenterologists' perspective and current practice in the United Kingdom.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

Colonoscopic polypectomy in chronic colitis: Conservative management after endoscopic resection of dysplastic polyps

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

Marking and identifying colon lesions. Tattoos, clips, and radiology in imaging the colon.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

Long-term safety of India ink tattoos in the colon.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

Narrow band imaging and multiband imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

Magnifying colonoscopy with narrow band imaging system for the diagnosis of dysplasia in ulcerative colitis: a pilot study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

Narrow-band imaging: potential and limitations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

Narrow-band imaging compared with conventional colonoscopy for the detection of dysplasia in patients with longstanding ulcerative colitis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

Endoscopic tri-modal imaging for surveillance in ulcerative colitis: randomised comparison of high-resolution endoscopy and autofluorescence imaging for neoplasia detection; and evaluation of narrow-band imaging for classification of lesions.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

Confocal laser endomicroscopy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

Chromoscopy-guided endomicroscopy increases the diagnostic yield of intraepithelial neoplasia in ulcerative colitis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.162

Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy

31 March 2020

1 reference

12 December 2020

Primary sclerosing cholangitis and ulcerative colitis: Evidence for increased neoplastic potential

1 reference

12 December 2020

Change in the extent of colonic involvement in ulcerative colitis: a colonoscopic study

1 reference

12 December 2020

Over-expression of p53 protein in neoplastic changes in ulcerative colitis: immunohistochemical study

1 reference

12 December 2020

Ulcerative colitis and colon cancer: biology and surveillance

1 reference

12 December 2020

10.1038/NRGASTRO.2009.162

Identifiers

DOI

1 reference

21 August 2017

1 reference